| Report ID |
3233 |
| Drug Identification Number |
02392534 |
| Brand name |
GABAPENTIN TABLETS USP |
| Common or Proper name |
GABAPENTIN |
| Company Name |
ACCORD HEALTHCARE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
GABAPENTIN |
| Strength(s) |
800MG |
| Dosage form(s) |
TABLET |
| Route of administration |
ORAL |
| Packaging size |
BOTTLE OF 100 TABS | BOUTEILLE DE 100 COMPRIMÉS |
| ATC code |
N03AX |
| ATC description |
ANTIEPILEPTICS |
| Reason for shortage |
Disruption of the manufacture of the drug. |
| Anticipated start date |
2016-12-06 |
| Actual start date |
2016-12-06 |
| Estimated end date |
2017-11-03 |
| Actual end date |
2017-11-08 |
| Shortage status |
Resolved |
| Updated date |
2017-11-13 |
| Company comments |
|
| Health Canada comments |
|
| Tier 3 Status |
No |
| Company contact information |
Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
